Cannabinoid hyperemesis syndrome explained
Cannabinoid hyperemesis syndrome is a three-phase cyclical syndrome characterized by periods of intense nausea and vomiting, frequently relieved with hot water bathing, that poses…
Pharmacology
New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc was previously…
The changing face of cystic fibrosis
It’s no longer a childhood illness. The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live…
Avoiding antipsychotic medication use in nursing home residents with dementia
Elderly patients using antipsychotic medications are at a 1.6 to 1.7 times increased of risk of death, and antipsychotic medications are associated with significant…
Study shows reduced risk of cardiovascular disease during times of bereavement with daily aspirin intake
A study published in the American Heart Journal explored the effects of aspirin and low dose metoprolol intake during early bereavement periods. (more…)
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)
First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment of adult patients with…
Promoting safe use of parenteral anticoagulants
Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with medical conditions…
10 years of inpatient diabetes certification— Lessons learned
Diabetes quality improvement (QI) in an inpatient academic hospital setting can be challenging because of communication gaps among staff, pre-established mealtime delivery schedules, complex…
Potential new targeted therapy for Duchenne muscular dystrophy
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval for Sarepta Therapeutics’ golodirsen (Vyondys 53), an injection for patients with Duchenne muscular…
Medical Cannabis: What Nurses Need to Know
Nurses frequently care for patients who use or are considering using medical cannabis. In 2018, the National Council of State Boards of Nursing (NCSBN)…
A medication dosage simulation strategy to improve patient safety
Simulation boosts skills and encourages active learning. Takeaways: Traditional medication administration dosage testing can be time-consuming, costly, and lack elements of active learning. Simulation…
Cannabinoid hyperemesis syndrome explained
Cannabinoid hyperemesis syndrome is a three-phase cyclical syndrome characterized by periods of intense nausea and vomiting, frequently relieved with hot water bathing,…
New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc…
The changing face of cystic fibrosis
It’s no longer a childhood illness. The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic…
Avoiding antipsychotic medication use in nursing home residents with dementia
Elderly patients using antipsychotic medications are at a 1.6 to 1.7 times increased of risk of death, and antipsychotic medications are associated…
Study shows reduced risk of cardiovascular disease during times of bereavement with daily aspirin intake
A study published in the American Heart Journal explored the effects of aspirin and low dose metoprolol intake during early bereavement periods.…
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)
First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment of adult…
Promoting safe use of parenteral anticoagulants
Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with…
10 years of inpatient diabetes certification— Lessons learned
Diabetes quality improvement (QI) in an inpatient academic hospital setting can be challenging because of communication gaps among staff, pre-established mealtime delivery…
Potential new targeted therapy for Duchenne muscular dystrophy
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval for Sarepta Therapeutics’ golodirsen (Vyondys 53), an injection for patients with…
Medical Cannabis: What Nurses Need to Know
Nurses frequently care for patients who use or are considering using medical cannabis. In 2018, the National Council of State Boards of…
A medication dosage simulation strategy to improve patient safety
Simulation boosts skills and encourages active learning. Takeaways: Traditional medication administration dosage testing can be time-consuming, costly, and lack elements of active…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.